Boström A A, Forbes J A, Adolfsson C, Beaver W T, Bell W E
Orthopedic Surgery Clinic, Central Hospital, Karlstad, Sweden.
Pharmacotherapy. 1994 May-Jun;14(3):305-13.
To determine the relative analgesic potency and adverse effect liability of bromfenac 25, 50, and 100 mg, and ibuprofen 200 and 400 mg in the treatment of postoperative pain after orthopedic surgery.
Randomized, double-blind, single-dose, parallel-group relative potency assay with evaluations at 30 minutes and then at hourly intervals for up to 6 hours.
Two wards of the orthopedic surgery department at the Centralsjukhuset (Central Hospital) in Karlstad, Sweden.
Two hundred inpatients with steady, moderate or severe pain within 72 hours after orthopedic surgery.
Patients received a single oral dose of bromfenac 25, 50, or 100 mg, or ibuprofen 200 or 400 mg, when they experienced steady, moderate or severe pain that, in their opinion, required an analgesic. Using a self-rating record, subjects rated their pain and its relief for 6 hours after medicating.
The study was a valid relative potency assay with estimates of bromfenac's potency relative to ibuprofen ranging from 10.9 (nurse's global evaluation) to 16.7 (sum of hourly analog pain intensity difference scores). That is, 11-16 times the dose of ibuprofen must be administered to equal the analgesic effect of bromfenac. Patients who had eaten breakfast or lunch within 60 minutes before or 30 minutes after receiving the study medication ("fed" patients) had lower efficacy scores than those who had not ingested food within these time constraints before or after receiving the study medication ("fasted" patients). Furthermore, patients who had eaten before receiving the study medication had significantly lower efficacy scores than those who had eaten after receiving the study medication.
The relative potency of the analgesic effect of bromfenac to ibuprofen is 11-16.7 in patients with pain after orthopedic surgery. Fed patients may have lower analgesic efficacy than fasted patients. Adverse effects for both bromfenac and ibuprofen were transient and consistent with the pharmacologic profiles of the drugs.
确定25毫克、50毫克和100毫克溴芬酸以及200毫克和400毫克布洛芬在治疗骨科手术后疼痛方面的相对镇痛效力和不良反应发生率。
随机、双盲、单剂量、平行组相对效力试验,在30分钟时进行评估,然后每小时评估一次,持续6小时。
瑞典卡尔斯塔德中央医院(Centralsjukhuset)骨科手术科的两个病房。
200名骨科手术后72小时内有持续中度或重度疼痛的住院患者。
当患者经历持续的中度或重度疼痛且认为需要使用镇痛药时,给予单次口服剂量的25毫克、50毫克或100毫克溴芬酸,或200毫克或400毫克布洛芬。受试者使用自评记录,在用药后6小时内对疼痛及其缓解情况进行评分。
该研究是一项有效的相对效力试验,溴芬酸相对于布洛芬的效力估计值在10.9(护士整体评估)至16.7(每小时模拟疼痛强度差异评分总和)之间。也就是说,必须给予布洛芬剂量的11 - 16倍才能达到与溴芬酸相同的镇痛效果。在接受研究药物前60分钟内或后30分钟内吃了早餐或午餐的患者(“进食”患者)的疗效评分低于在接受研究药物前后这些时间限制内未摄入食物的患者(“禁食”患者)。此外,在接受研究药物前吃东西的患者的疗效评分显著低于在接受研究药物后吃东西的患者。
在骨科手术后疼痛的患者中,溴芬酸的镇痛效果相对于布洛芬的相对效力为11 - 16.7。进食患者的镇痛效果可能低于禁食患者。溴芬酸和布洛芬的不良反应都是短暂的,且与药物的药理学特征一致。